Open AccessSurgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival☆
Author(s) -
Herbert Decaluwé,
Paul De Leyn,
Johan Vansteenkiste,
Christophe Dooms,
Dirk Van Raemdonck,
Philippe Nafteux,
Willy Coosemans,
Antoon Lerut
Publication year - 2009
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2009.04.013
Subject(s) - medicine , mediastinal lymph node , stage (stratigraphy) , lymph node , oncology , radiology , surgery , cancer , metastasis , paleontology , biology
Analysis of single centre results and identification of prognostic factors of surgical combined modality treatment in pathological proven stage IIIA-N2 non-small cell lung cancer (NSCLC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom